Highlights
NASDAQ: BMRN       Biomarin Pharmaceut
Last Price Today's Change   Day's Range   Trading Volume
89.12   -0.11 (0.12%)  88.81 - 90.085  174,319

Overview

 
Avg Volume (4 weeks):1,394,821
4 Weeks Range:88.36 - 100.51
4 Weeks Price Volatility (%):
6.26%
52 Weeks Range:73.45 - 102.49
52 Weeks Price Volatility (%):
53.96%
Average Price Target: 133.00
Price Target Upside/Downside: +43.88

Headlines



No recent Headlines for this stock.


Business Background

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

  Be the first to like this.
 


 

3377  3203  749  1034 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GPACW 0.20-0.14 
 NTRSP 27.04-0.04 
 F 11.03+0.16 
 BAC 22.87-0.18 
 AMD 11.055-0.355 
 XLF 23.29-0.06 
 DCTH 0.030.00 
 TVIX 26.12-2.05 
 PBR 8.625-0.335 
 HUN 26.688-0.022 
Partners & Brokers